Phase II trial of doxorubicin and paclitaxel plus granulocyte colony- stimulating factor in metastatic breast cancer: An eastern cooperative oncology group study
Research output: Contribution to journal › Article › peer-review
56Scopus
citations
Fingerprint
Dive into the research topics of 'Phase II trial of doxorubicin and paclitaxel plus granulocyte colony- stimulating factor in metastatic breast cancer: An eastern cooperative oncology group study'. Together they form a unique fingerprint.